Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.

被引：0
|
作者：
Leapman, Michael
Sutherland, Ryan Andrew
Gross, Cary Philip
Ma, Xiaomei
Jeong, Farah
Seibert, Tyler M.
Cooperberg, Matthew R.
Catalona, William
Loeb, Stacy
Schulman-Green, Dena
机构：
[1] Yale Univ, New Haven, CT USA
[2] Yale Sch Med, New Haven, CT USA
[3] Yale Canc Outcomes Publ Policy & Effectiveness Re, New Haven, CT USA
[4] Yale Sch Publ Hlth, New Haven, CT USA
[5] Univ Calif San Diego, La Jolla, CA USA
[6] Univ Calif San Francisco, San Francisco, CA USA
[7] Northwestern Univ, Chicago, IL USA
[8] New York Univ, New York, NY USA
[9] Manhattan Vet Affairs, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
333
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Germline Testing for Prostate Cancer Prognosis Implications for Active Surveillance
    Helfand, Brian T.
    Xu, Jianfeng
    UROLOGIC CLINICS OF NORTH AMERICA, 2021, 48 (03) : 401 - 409
  • [32] 'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer
    Sutherland, Ryan
    Gross, Cary P.
    Ma, Xiaomei
    Jeong, Farah
    Seibert, Tyler M.
    Cooperberg, Matthew R.
    Catalona, William J.
    Ellis, Shellie D.
    Loeb, Stacy
    Schulman-Green, Dena
    Leapman, Michael S.
    BJUI COMPASS, 2024, 5 (06): : 593 - 601
  • [33] Introduction to the Symposium on "Discovery and Development of Tissue-Based Biomarkers in Prostate Cancer"
    Knudsen, BS
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S6 - S6
  • [34] Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
    Gao, Yuqian
    Wang, Yi-Ting
    Chen, Yongmei
    Wang, Hui
    Young, Denise
    Shi, Tujin
    Song, Yingjie
    Schepmoes, Athena A.
    Kuo, Claire
    Fillmore, Thomas L.
    Qian, Wei-Jun
    Smith, Richard D.
    Srivastava, Sudhir
    Kagan, Jacob
    Dobi, Albert
    Sesterhenn, Isabell A.
    Rosner, Inger L.
    Petrovics, Gyorgy
    Rodland, Karin D.
    Srivastava, Shiv
    Cullen, Jennifer
    Liu, Tao
    CANCERS, 2020, 12 (05)
  • [35] Active surveillance in prostate cancer: patient selection and triggers for intervention
    Lees, Kathryn
    Durve, Meeta
    Parker, Chris
    CURRENT OPINION IN UROLOGY, 2012, 22 (03) : 210 - 215
  • [36] Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance
    Eltemamy, Mohamed M.
    Leapman, Michael S.
    Cowan, Janet E.
    Westphalen, Antonio
    Shinohara, Katsuto
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2016, 196 (03): : 727 - 732
  • [37] How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States
    Loeb, Stacy
    Walter, Dawn
    Curnyn, Caitlin
    Gold, Heather T.
    Lepor, Herbert
    Makarov, Danil V.
    JOURNAL OF UROLOGY, 2016, 196 (03): : 721 - 726
  • [38] Descriptive analysis of patients on active surveillance escalating to treatment for localized prostate cancer.
    Son, Young
    Wu, Edward
    Akanda, Shawon
    Klimowich, Katelyn
    Mueller, Thomas
    Brown, Gordon Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] The prognostic impact of a negative confirmatory biopsy in men on active surveillance for prostate cancer.
    Salari, Keyan
    Zlatev, Dimitar V.
    Kuppermann, David
    Preston, Mark A.
    Dahl, Douglas M.
    Efstathiou, Jason A.
    Blute, Michael L.
    Zietman, Anthony L.
    Feldman, Adam S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Nationwide analysis of genitourinary expert opinions on active surveillance for localized prostate cancer.
    McClelland, Shearwood
    Sandler, Kiri A.
    Degnin, Catherine
    Chen, Yiyi
    Mitin, Timur
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
12345